
Granisetron Patch
Form: Patches
Strength: 3.1 mg patch
Reference Brands: Sancuso
Category: Transdermal Patches
Granisetron patches are regulated in the EU and US, with dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involved clinical validation, safety assessments, and GMP compliance, while in the EU, CE marking certifies conformity with MDR standards. These products undergo validation, stability testing, and audits, supported by comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to reliable, effective antiemetic therapy supporting cancer patients worldwide, improving treatment comfort, adherence, and quality of life during chemotherapy and radiation therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Rotigotine Patch
Strength: 2 mg/24 hr, 4 mg/24 hr, 6 mg/24 hr, 8 mg/24 hr, and 12 mg/24 hr
Form: Patches
Reference Brands: Neupro
View DetailsSelegiline Patch
Strength: 6 mg/24 hr, 9 mg/24 hr, and 12 mg/24 hr patches
Form: Patches
Reference Brands: Emsam
View Details.Scopolamine Patch
Strength: 1.5 mg patch
Form: Patches
Reference Brands: Transderm-Scop
View DetailsNicotine Patch
Strength: 7 mg, 14 mg, 21 mg patches
Form: Patches
Reference Brands: Nicoderm CQ
View Details